# US 2008/0287879 A1 · System and method for treating erectile dysfunction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0287879 A1
- Document ID: US20080287879A1
- Status: Published application
- Kind: A1
- Application number: 12/122,023
- Filed: 2008-05-16
- Published: 2008-11-20
- Earliest claimed: 2007-05-16
- Assignees: Health Knight, LLC
- Inventors: Thomas John Harkins, JR.
- Web page: https://patentgrep.com/patent/US20080287879A1

## CPC

- A61F 5/41: Devices for promoting penis erection
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/417: Imidazole-alkylamines, e.g. histamine, phentolamine
- A61K 31/472: Non-condensed isoquinolines, e.g. papaverine
- A61M 5/19: having more than one chamber
- A61M 31/00: Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008})
- A61M 5/2066: {comprising means for injection of two or more media, e.g. by mixing}
- A61M 2210/1089: Urethra
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A treatment for male erectile dysfunction comprising separately storing a lyophilized composition of vasoactive agents and a carrier gel, mixing said lyophilized composition of vasoactive agents and said carrier gel creating a homogeneous mixture and applying said homogeneous mixture to the meatus of the glans penis. A system for the treatment of male erectile dysfunction comprising a syringe coupling system for the storage, mixing and application of therapeutic compounds for the treatment of erectile dysfunction, said system further comprising a first syringe and a second syringe. The first and second syringes are filled with a lyophilized composition of vasoactive agents or a carrier gel. The system includes a locking device coupling said syringes to facilitate the transfer of said lyophilized composition of vasoactive agents and carrier gel between the syringes and a penile adapter for applying the therapeutic compounds for the treatment of erectile dysfunction to the meatus of the glans penis.

## Claims

### Claim 1

A method for the treatment of male erectile dysfunction comprising the steps of:
storing a lyophilized composition of vasoactive agents separately from a carrier gel;
mixing said lyophilized composition of vasoactive agents and said carrier gel to create a homogeneous mixture for erectile dysfunction treatment; and
applying said homogeneous mixture to a meatus of a glans penis.

### Claim 2 (depends on 1)

The method claim 1, wherein said lyophilized composition of vasoactive agents comprises one or more vasodilators and a vasoactive prostaglandin.

### Claim 3 (depends on 2)

The method of claim 2, wherein said vasoactive prostaglandin is selected from the group consisting of prostaglandin E1, alprostadil, prostaglandin E2, synthetic prostaglandins, misoprostol, enprostil, and analogs thereof.

### Claim 4 (depends on 2)

The method of claim 2, wherein said vasodilators comprises an alpha-adrenergic blocker and a phosphodiesterase inhibitor.

### Claim 5 (depends on 2)

The method of claim 2, wherein said vasodilators are selected from the group consisting of papaverine, phentolamine, atropine, niacin, prazosin, doxazosin, terazosin, minoxidil and mixtures thereof.

### Claim 6 (depends on 2)

The method of claim 2, wherein said lyophilized composition of vasoactive agents comprises alprostadil, papaverine and phentolamine.

### Claim 7 (depends on 1)

The method of claim 1, wherein said carrier gel is a high-weight cellulose based gel.

### Claim 8 (depends on 1)

The method of claim 1, wherein said carrier gel further comprises at least one pain-reducing additive.

### Claim 9 (depends on 1)

The method of claim 1, wherein said homogeneous mixture for erectile dysfunction treatment has a pH level of at least 9.

### Claim 10

A syringe coupling system for the storage, mixing and application of therapeutic compounds for the treatment of erectile dysfunction, said system further comprising:
a first syringe having a first cavity wherein a lyophilized composition of vasoactive agents is stored within said first cavity;
a second syringe having a second cavity wherein a carrier gel is stored within said second cavity;
a locking device adapted for coupling said first and said second syringes together to transfer said lyophilized composition of vasoactive agents and said carrier gel between said first and second syringes, wherein said first and second cavities are in fluid communication; and
a penile adapter having a bottom portion for attachment to one of said first or said second syringes and having a hole therethrough for transferring said therapeutic compounds from one of said first or said second syringe to a meatus of a glans penis.

### Claim 11 (depends on 10)

The syringe coupling system of claim 10, wherein said locking device further comprises:
a tubular member having an interior surface and an exterior surface, said tubular member having a longitudinal axis extending therethrough, wherein said tubular member is a tip of said first syringe;
a pair of threads outwardly projecting from the exterior surface of said tubular member at least partially encircling said tubular member, at least a portion of each of the pair of threads disposed in a plane perpendicular to said longitudinal axis of said tubular member, said threads bounding a thread groove;
a collar member having an interior surface and an exterior surface, said collar member having a longitudinal axis extending therethrough, wherein said collar member is a tip outlet tip of said second syringe; and
a pair of engagement threads outwardly projecting from the interior surface of said collar member, at least a portion of each of the engagement threads being disposed in a plane perpendicular to said longitudinal axis of said collar member;
wherein said collar member of said second syringe is configured to accept said tubular member of said first syringe such that said threads couple with said engagement threads.

### Claim 12

A penile adapter for use in the application of therapeutic compounds for the treatment of erectile dysfunction, said penile adapter comprising:
a top portion having a substantially spheroidal dome shape having an open channel therethrough, said top portion shaped to substantially seal a meatus of a glans penis; and
a bottom portion having a substantially cylindrical shape having an open channel therethrough, said bottom portion being removably attached to a device which stores and discharges medical compounds;
wherein said open channel of the top portion is in fluid communication with said open channel of the bottom portion to facilitate the flow of said therapeutic compounds from said device to the meatus of the glans penis.

### Claim 13 (depends on 12)

The penile adapter of claim 12, wherein said device which stores and discharges medical compounds is a syringe.

### Claim 14 (depends on 12)

The penile adapter of claim 12, wherein said top portion of the penile adapter is further shaped to prevent penetration of the adapter past a meatal opening of the penis.

### Claim 15 (depends on 12)

The penile adapter of claim 12, wherein said penile adapter is made from a polyethylene based material.

### Claim 16

A method of applying therapeutic compounds for the treatment of erectile dysfunction comprising the steps of:
storing a lyophilized composition of vasoactive agents in a first syringe;
storing a carrier gel in a second syringe;
mixing said lyophilized composition of vasoactive agents and said carrier gel to create a homogeneous therapeutic compound using a locking device, said device allowing the transfer of said lyophilized composition of vasoactive agents and said carrier gel between said syringes, the repeated transfer creating a homogeneous mixture for erectile dysfunction treatment;
transferring said homogeneous mixture for erectile dysfunction treatment into said first syringe;
fitting a penile adapter to said first syringe; and
discharging said homogeneous mixture for erectile dysfunction treatment onto a meatus of a glans penis.
